Combination of viral oncolysis and tumor-specific immunity to control established tumors - Wikidata - awgldk - TriplyDB

Combination of viral oncolysis and tumor-specific immunity to control established tumors

Combination of viral oncolysis and tumor-specific immunity to control established tumors

http://www.wikidata.org/entity/Q34793516

about

Thunder and lightning: immunotherapy and oncolytic viruses collide Potentiating cancer immunotherapy using an oncolytic virus Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Efficient delivery of DNA vaccines using human papillomavirus pseudovirions Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells.Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model.Evolution of oncolytic viruses: novel strategies for cancer treatment.Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity.Oncolytic Virotherapy and the Tumor Microenvironment.Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies.

P2860

Q24597894-2FC92177-797F-4DBD-B8A1-1F996C94D155 Q24628810-9BABDBDD-4623-4F60-983F-B1530AFE1018 Q33906116-84091751-2EB7-4C35-9F58-0C5E3E9B7436 Q34274080-90771314-9949-431C-BA7B-C5BB88D99C89 Q34556927-4CB0476C-8BEF-470B-8479-FB2CB5DF8A52 Q36544867-BF29E22B-4586-4ADC-9063-5C0B18E93F36 Q37700567-095C9BC2-9177-4561-A03D-ADDE9CDD9B0D Q38159802-F786D7D0-C2FF-4638-97FF-D4F277937A95 Q40063602-BA44A6FC-5613-47E6-ABD9-97284B27ED35 Q47560690-E15FCDA3-0087-4B92-AA13-906D03B25A9A Q50865520-69359684-0255-4CE5-B415-16A5592416EB

P2860

Combination of viral oncolysis and tumor-specific immunity to control established tumors

http://www.wikidata.org/entity/Q34793516

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@ast

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@en

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@nl

type

label

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@ast

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@en

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@nl

prefLabel

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@ast

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@en

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@nl

P1433

Q34793516-F16EF368-DCE1-4C7D-8EFA-6EC0FC7972F0

P1476

Q34793516-20D8CAF5-AE35-4EF7-913C-73C434A61E70

P2093

Q34793516-3EC9B746-7DF0-4E67-A31A-5E4EBEDD98CC

Q34793516-42A8AF21-C7D9-4E84-9751-848363F64522

Q34793516-48F9293E-87AE-4D3C-B907-245565D26D8E

Q34793516-9E901086-348E-415C-A5F8-9F5CE405FD3B

Q34793516-AC6559FB-DAAF-44B2-887A-3C3D20037E22

P2860

Q34793516-0DAE1488-7F8A-49AB-A244-8FF1F2D5FBA0

Q34793516-308D2B81-E36B-44E8-946B-791454DE3D07

Q34793516-355B5613-AA33-4281-99C1-CF63F6AE822B

Q34793516-386ED9B6-41AB-4D84-B6FC-4F1825A824B4

Q34793516-3C1F3A90-BC55-4BF6-ADA8-910BCADA9729

Q34793516-489245F0-1207-4811-980F-3F302E845726

Q34793516-49C43929-6C06-4E94-A5B4-960CB5EA4DC3

Q34793516-4BAD538B-FDA6-45EC-9487-AEEAB797F74B

Q34793516-66F7E935-C856-458A-A2AC-D035AFE4B3B8

Q34793516-6C667F7A-A008-451D-B45B-5795C6B90ECB

P304

Q34793516-8C9E5319-E1E6-4275-998B-73B733B17F8E

P31

Q34793516-288DC7F9-D48C-4ADC-8596-9B283C89D3C9

P356

Q34793516-18617B51-70F2-4B30-91B1-4D4846DF43FB

P407

Q34793516-1760B4AB-E76B-4035-87BF-DB6A206514B6

P433

Q34793516-101AA7C9-F5D7-450B-9D15-EBF4782660E7

P478

Q34793516-AF990E0D-CA58-4CA4-A937-9F72034FCFD2

P577

Q34793516-2598D2EC-2A7F-487B-8A06-D6BC84D9075F

P698

Q34793516-FD1B7A10-7644-4DF5-BD2B-880AF12DC917

P932

Q34793516-4447893E-F0FF-4BDE-82C0-48A839611BE8

P356

1078-0432.CCR-08-2685

P1433

Clinical Cancer Research

P1476

Combination of viral oncolysis and tumor-specific immunity to control established tumors

@en

P2093

Annie Wu

http://www.w3.org/2001/XMLSchema#string

Archana Monie

http://www.w3.org/2001/XMLSchema#string

Chi-Mu Chuang

http://www.w3.org/2001/XMLSchema#string

Chien-Fu Hung

http://www.w3.org/2001/XMLSchema#string

Sara I Pai

http://www.w3.org/2001/XMLSchema#string

P2860

Pox, dyes, and videotape: making movies of GFP-labeled vaccinia virus.

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins.

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.

The role of stroma in immune recognition and destruction of well-established solid tumors.

Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model

Selection of therapy for stage III breast cancer.

P304

4581-4588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-2685

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19584165

http://www.w3.org/2001/XMLSchema#string

P932

3076709

http://www.w3.org/2001/XMLSchema#string